Analyst Ratings for Cytek Biosciences Inc (CTKB)
CTKB Rating Summary
CTKB Price Target Summary
- Highest: $7.50 (Piper Sandler)
- Lowest: $5.00 (TD Cowen)
- Average: $6.17
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$6.17 (+46.1%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Avg. $ Target:
$6.17 (+46.1%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/2/2025 | Morgan Stanley | Kallum Titchmarsh | New Coverage | Equalweight (N/A) |
6.00 (N/A) |
5.65 (4.22) |
-25.31% | Details |
| 5/9/2025 | TD Cowen » Updated 1/8/2026 |
Brendan Smith | Downgrade | Hold (Buy) |
5.00 (4.00) |
3.79 (4.22) |
11.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
